NextCure Inc. (NXTC)
NASDAQ: NXTC
· Real-Time Price · USD
5.72
0.02 (0.35%)
At close: Sep 29, 2025, 3:59 PM
5.66
-1.05%
After-hours: Sep 29, 2025, 07:56 PM EDT
0.35% (1D)
Bid | 5.7 |
Market Cap | 15.31M |
Revenue (ttm) | 3.28M |
Net Income (ttm) | -60.93M |
EPS (ttm) | -25.97 |
PE Ratio (ttm) | -0.22 |
Forward PE | -0.48 |
Analyst | Buy |
Dividends | n/a |
Ask | 5.88 |
Volume | 7 |
Avg. Volume (20D) | 113,484 |
Open | 5.77 |
Previous Close | 5.70 |
Day's Range | 5.71 - 5.79 |
52-Week Range | 2.69 - 19.20 |
Beta | 1.27 |
Ex-Dividend Date | n/a |
About NXTC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NXTC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NXTC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+1.15%
NextCure shares are trading higher after the compa...
Unlock content with
Pro Subscription
10 months ago
+1.55%
NextCure shares are trading higher after the company highlighted data demonstrating that NC605 resulted in enhanced generation of quality bone and better mechanical properties.